Melasma & Hyperpigmentation

Melasma is a common, chronic skin condition that causes symmetrical brown, tan, or gray-brown patches of hyperpigmentation, most often on the face, driven by overactive pigment-producing cells. Hyperpigmentation is the broader umbrella term for any darkening of the skin from excess melanin — melasma is one specific, often stubborn, sun- and hormone-related form of it.

What is melasma and hyperpigmentation?

Hyperpigmentation simply means areas of skin that are darker than the surrounding skin. It happens when melanocytes — the cells that make the pigment melanin — produce too much, or deposit it unevenly. There are several distinct types, and telling them apart matters because they are treated differently:

• Melasma — symmetrical patches, usually on the face, linked to sun, hormones, and genetics.
• Post-inflammatory hyperpigmentation (PIH) — dark spots left behind after acne, eczema, injury, or a skin procedure.
• Solar lentigines ("age spots" or "sun spots") — discrete flat brown spots from cumulative sun damage.
• Freckles (ephelides) — small, genetically determined spots that darken with sun.

Melasma (ICD-10 code L81.1) typically appears as ill-defined, blotchy patches with a "lacy" or map-like border. It favors the centrofacial pattern (forehead, cheeks, nose, upper lip, chin), the malar pattern (cheeks and nose), and the mandibular pattern (jawline). It can also occur on sun-exposed areas like the forearms and neck. When melasma develops during pregnancy it is often called chloasma or the "mask of pregnancy."

Melasma is benign — it is not skin cancer, it is not contagious, and it carries no physical health risk. But because it is highly visible and prone to relapse, it commonly affects quality of life and confidence, which is why effective, evidence-based management matters.

What causes melasma and who's at risk?

Melasma arises from an interaction of several triggers rather than a single cause (StatPearls). The three most established drivers are:

Ultraviolet and visible light

Sun exposure is the single most important and modifiable trigger. UV radiation stimulates melanocytes to produce more melanin, and research shows that visible light (including high-energy blue light from the sun and, to a lesser extent, screens) can also worsen melasma — particularly in people with darker skin. This is why melasma flares in summer and fades somewhat in winter, and why sun protection is the cornerstone of every treatment plan.

Hormones

Melasma is strongly associated with female sex hormones (estrogen and progesterone). Common hormonal triggers include pregnancy, combined oral contraceptives, and hormone replacement therapy. The pregnancy-related "mask of pregnancy" frequently appears in the second or third trimester and often fades on its own in the months after delivery or after stopping hormonal contraception (Harvard Health), though it does not always resolve completely.

Genetics

A large share of people with melasma report a family history, indicating an inherited susceptibility in how their melanocytes respond to triggers.

Who is most at risk:

• Women — the overwhelming majority of cases occur in women, although men can develop melasma too.
• People with medium-to-darker skin — melasma is most common in Fitzpatrick skin phototypes III–VI, including people of Hispanic/Latino, South and East Asian, Middle Eastern, Mediterranean, and African descent.
• Adults of reproductive age — onset is typically between the late 20s and 40s.
• People with high sun exposure — those living in sunny climates or with significant outdoor exposure.

Other contributing factors can include certain medications and cosmetics that cause skin irritation or photosensitivity, and possibly thyroid dysfunction. Importantly, melasma is now understood to be more than a pigment problem — research points to involvement of the skin's blood vessels, a disrupted skin barrier, and signs of photoaging in affected skin, which helps explain why it can be so persistent (PMID 36817641, "New Mechanistic Insights of Melasma," *Clin Cosmet Investig Dermatol* 2023).

What are the symptoms?

Melasma is defined by its appearance, not by physical sensations. Key features:

• Flat patches or freckle-like clusters of discoloration — never raised, scaly, itchy, or painful.
• Color ranging from light tan to deep brown, and sometimes blue-gray (in dermal or mixed types).
• Symmetry — patches usually appear on both sides of the face in a mirror-image pattern.
• Common locations — cheeks, bridge of the nose, forehead, upper lip ("mustache" area), and chin; sometimes the jawline, forearms, and neck.
• Gradual onset and worsening with sun exposure; partial fading in winter or with sun avoidance.

If a pigmented spot is itchy, painful, bleeding, rapidly changing, raised, has irregular or jagged borders, or contains multiple colors within a single lesion, it is not typical melasma and should be evaluated promptly to rule out other conditions, including skin cancer.

How is melasma diagnosed?

Melasma is usually a clinical diagnosis — a dermatologist or clinician recognizes it by its characteristic symmetrical pattern and history. Several tools support and refine the diagnosis:

• Visual examination and history — assessing pattern, distribution, skin phototype, and triggers such as pregnancy, contraceptive use, and sun exposure.
• Wood's lamp examination — an ultraviolet light that helps determine pigment depth, especially in lighter skin (phototypes I–III). Under the lamp, a well-defined, enhanced border suggests pigment in the epidermis (surface layer), a blurred, non-enhanced border suggests deeper dermal pigment, and a combination indicates mixed-type melasma. Pigment depth influences how well treatment is likely to work — epidermal melasma generally responds best.
• Dermoscopy — magnified surface examination to evaluate pigment patterns and the blood-vessel changes often seen in melasma.
• Skin biopsy — rarely needed, reserved for atypical cases to exclude other diagnoses.

For tracking severity and treatment response, clinicians often use the Melasma Area and Severity Index (MASI), a standardized score based on the area involved, the darkness of the pigment, and how uniform (homogeneous) it is. MASI is used mainly in clinical practice and research to objectively measure improvement over time rather than as a diagnostic threshold.

How is melasma treated?

Melasma is treatable but chronic and relapse-prone, so the goals are to lighten existing pigment, prevent new pigment, and maintain results long-term. Treatment is layered, starting with foundational measures and escalating under medical supervision. Patience is essential — meaningful improvement typically takes 8–12 weeks or longer.

Foundation: sun protection and lifestyle (for everyone)

No treatment works without rigorous photoprotection.

• Broad-spectrum SPF 30–50, applied generously every morning and reapplied roughly every two hours with sun exposure.
• Tinted sunscreens containing iron oxides, which block visible light far better than standard mineral or chemical sunscreens — a key, evidence-supported step for melasma specifically.
• Physical measures: wide-brimmed hats, shade, and sunglasses.
• Identify and address hormonal triggers where appropriate — for example, discussing non-hormonal contraception with a clinician if combined oral contraceptives appear to be a factor.
• Avoid skin irritation: harsh scrubs, aggressive products, and waxing of affected areas can worsen pigmentation.

Over-the-counter and cosmetic options

For milder cases or maintenance, several topical ingredients can gradually lighten pigment:

• Azelaic acid, vitamin C (ascorbic acid), niacinamide, kojic acid, arbutin, and cysteamine.
• Low-strength retinoids (e.g., retinol) to support cell turnover.
• Camouflage makeup can provide immediate cosmetic coverage while medical treatment takes effect.

Prescription options

For moderate-to-severe or persistent melasma, dermatologists turn to prescription therapy:

• Hydroquinone — a topical skin-lightening agent that is the most studied single treatment for melasma, used in supervised courses to limit side effects.
• Triple-combination cream — the topical gold standard, combining hydroquinone, a retinoid (tretinoin), and a low-potency corticosteroid (fluocinolone acetonide). Guideline-aligned use is typically continued for a defined period and not indefinitely, because of side-effect risks with prolonged hydroquinone and steroid use ("Update on Melasma Treatments," *Ann Dermatol* 2024, PMC11148313).
• Topical tranexamic acid — increasingly used and supported as a first-line or adjunctive topical option for mild-to-moderate melasma.
• Oral tranexamic acid — a low-dose oral medication used by specialists for resistant melasma. It requires medical screening, as it carries a (rare) risk of blood clots and is not appropriate for everyone.
• Other prescription topicals such as azelaic acid (prescription strength) and adjunctive antioxidants.

Procedural treatments

Used cautiously and usually after topicals, since aggressive procedures can paradoxically worsen melasma (especially in darker skin):

• Chemical peels (e.g., glycolic acid).
• Microneedling, sometimes combined with topical tranexamic acid.
• Lasers and light-based devices (such as low-fluence Q-switched or picosecond lasers) — these are best performed by experienced clinicians with conservative settings.

The American Academy of Dermatology (AAD) and recent expert consensus statements emphasize a stepwise, individualized approach centered on photoprotection, topical therapy first, and careful escalation, with particular caution in skin of color.

Can melasma be prevented or managed long-term?

Melasma cannot always be prevented, but its onset and recurrence can be substantially reduced, and it is best thought of as a long-term condition to manage rather than cure.

Effective long-term strategies include:

• Daily, year-round broad-spectrum and visible-light photoprotection — the most important factor in preventing relapse. Tinted, iron-oxide sunscreens are particularly valuable.
• Maintenance topical therapy under a clinician's guidance (for example, transitioning off hydroquinone-containing combinations to gentler agents like azelaic acid or vitamin C between flares).
• Managing hormonal triggers where feasible.
• Avoiding skin irritants and harsh treatments.
• Realistic expectations — melasma waxes and wanes, often improving in winter and flaring in summer; consistency matters more than intensity.

Because sun and hormones drive relapse, even well-cleared melasma commonly returns after sun exposure, pregnancy, or stopping treatment — so ongoing maintenance is the norm, not a sign of failure.

When should you see a doctor?

Melasma itself is harmless, but professional evaluation is worthwhile to confirm the diagnosis, rule out other causes, and build an effective plan. See a clinician or dermatologist if:

• New or persistent facial pigmentation is bothering you or not improving with sun protection.
• Over-the-counter products aren't working after a few months, or you want prescription-strength treatment.
• You're pregnant or breastfeeding and considering treatment (some agents, including hydroquinone and oral tranexamic acid, are generally avoided — confirm safe options with your clinician).

Seek prompt medical evaluation — these are red flags that suggest something other than melasma:

• A pigmented spot that is asymmetric, has irregular or notched borders, contains multiple colors, is larger than about 6 mm, or is changing in size, shape, or color (the "ABCDE" warning signs of melanoma).
• Any spot that itches, bleeds, crusts, becomes painful, or fails to heal.
• A single new dark lesion that looks different from your other spots (the "ugly duckling" sign).

These features warrant evaluation to exclude skin cancer and other dermatologic conditions.

What's the outlook (prognosis)?

The outlook for melasma is good in terms of health but variable in terms of clearance. It is entirely benign and never becomes cancerous. Many cases — especially pregnancy- or contraceptive-related melasma — fade significantly within months once the hormonal trigger is removed, particularly with diligent sun protection. Epidermal (surface) melasma generally responds better to treatment than dermal or mixed types.

That said, melasma is notoriously chronic and recurrent. Most people achieve meaningful lightening with consistent treatment, but complete and permanent clearance is uncommon, and flares are expected with sun exposure or hormonal changes. With realistic expectations and ongoing maintenance — above all, rigorous photoprotection — most people can keep their melasma well controlled over the long term.

Frequently asked questions

Will my pregnancy melasma go away after I give birth?

Often, yes — at least partially. Melasma triggered by pregnancy commonly fades after delivery or after stopping hormonal contraception (Harvard Health); in one study of pregnancy-related melasma, most cases faded within a year of delivery, but about 30% persisted longer. However, it doesn't always disappear completely, and sun exposure can keep it active. Diligent daily sunscreen helps it resolve faster and reduces the chance it persists. Because several treatments are avoided in pregnancy and breastfeeding, ask your clinician which options are safe before starting anything.

Is melasma the same as age spots or sun spots?

No. Age spots (solar lentigines) are discrete, well-defined individual spots caused mainly by cumulative sun damage, and they're usually easier to treat. Melasma is broader, blotchy, symmetrical, hormonally influenced, and far more prone to recurrence. The distinction matters because treatments and expectations differ.

Can melasma be cured permanently?

Melasma is best described as manageable rather than curable. Treatments can lighten it significantly, but because the underlying tendency remains and triggers like sun and hormones persist, it commonly recurs. Long-term control with photoprotection and maintenance therapy is the realistic goal.

Does sunscreen really make a difference if I'm already indoors most of the day?

Yes. Melasma is sensitive to both UV and visible light, and meaningful exposure occurs through windows, during brief outdoor periods, and on cloudy days. Broad-spectrum sunscreen — ideally a tinted formula with iron oxides to block visible light — applied daily and reapplied with exposure is the most effective single thing you can do to prevent worsening and relapse.

Are hydroquinone and tranexamic acid safe?

Both are widely used and effective when prescribed and monitored appropriately. Hydroquinone is the most-studied lightening agent but is used in supervised, time-limited courses to avoid side effects with prolonged use. Oral tranexamic acid is reserved for harder-to-treat cases and requires screening, since it carries a small risk of blood clots and isn't suitable for everyone. A clinician can determine what's right for your situation.

---

*This page is for general educational purposes and is independently reviewed; it is not medical advice. Always consult a qualified healthcare professional about diagnosis and treatment for your individual situation.*